BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33073585)

  • 1. The complicated role of mitochondria in the podocyte.
    Gujarati NA; Vasquez JM; Bogenhagen DF; Mallipattu SK
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F955-F965. PubMed ID: 33073585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Lon protease 1 expression in podocytes contributes to the pathogenesis of podocytopathy.
    Gong W; Song J; Liang J; Ma H; Wu W; Zhang Y; Yang L; Huang S; Jia Z; Zhang A
    Kidney Int; 2021 Apr; 99(4):854-869. PubMed ID: 33181155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofactors regulating mitochondrial function and dynamics in podocytes and podocytopathies.
    Hejazian SM; Ardalan M; Hosseiniyan Khatibi SM; Rahbar Saadat Y; Barzegari A; Gueguen V; Meddahi-Pellé A; Anagnostou F; Zununi Vahed S; Pavon-Djavid G
    J Cell Physiol; 2023 Oct; 238(10):2206-2227. PubMed ID: 37659096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrinuria and podocytopathies.
    Kostovska I; Trajkovska KT; Topuzovska S; Cekovska S; Labudovic D; Kostovski O; Spasovski G
    Adv Clin Chem; 2022; 108():1-36. PubMed ID: 35659057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy and podocytopathy.
    Ponticelli C; Moroni G; Reggiani F
    Nephrol Dial Transplant; 2023 Aug; 38(9):1931-1939. PubMed ID: 36708169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
    Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
    Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte energy metabolism and glomerular diseases.
    Imasawa T; Rossignol R
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2109-18. PubMed ID: 23806869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney Disease.
    Popovic ZV; Bestvater F; Krunic D; Krämer BK; Bergner R; Löffler C; Hocher B; Marx A; Porubsky S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury.
    Su M; Dhoopun AR; Yuan Y; Huang S; Zhu C; Ding G; Liu B; Yang T; Zhang A
    Am J Physiol Renal Physiol; 2013 Aug; 305(4):F520-31. PubMed ID: 23761667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
    Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
    J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.
    Casalena G; Krick S; Daehn I; Yu L; Ju W; Shi S; Tsai SY; D'Agati V; Lindenmeyer M; Cohen CD; Schlondorff D; Bottinger EP
    Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1372-80. PubMed ID: 24598802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury.
    Zhu C; Xuan X; Che R; Ding G; Zhao M; Bai M; Jia Z; Huang S; Zhang A
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1410-7. PubMed ID: 24808537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
    Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
    Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could Autophagic Exhaustion Be a Final Common Pathway for Podocytopathy in FSGS?
    Venkatachalam MA
    J Am Soc Nephrol; 2015 May; 26(5):999-1001. PubMed ID: 25406340
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirtuins as novel pharmacological targets in podocyte injury and related glomerular diseases.
    Liu T; Yang L; Mao H; Ma F; Wang Y; Li S; Li P; Zhan Y
    Biomed Pharmacother; 2022 Nov; 155():113620. PubMed ID: 36122519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Podocyte Biology.
    Garg P
    Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury.
    Arif E; Solanki AK; Srivastava P; Rahman B; Fitzgibbon WR; Deng P; Budisavljevic MN; Baicu CF; Zile MR; Megyesi J; Janech MG; Kwon SH; Collier J; Schnellmann RG; Nihalani D
    Kidney Int; 2019 Sep; 96(3):656-673. PubMed ID: 31262488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.